Edgewood Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$638M Sell
693,457
-562,232
-45% -$570M 4.12% 12
2025
Q4
$1.35B Sell
1,255,689
-923,739
-42% -$883M 6.43% 4
2025
Q3
$1.66B Buy
2,179,428
+196,611
+10% +$146M 5.89% 7
2025
Q2
$1.55B Sell
1,982,817
-102,196
-5% -$79.4M 4.91% 7
2025
Q1
$1.72B Sell
2,085,013
-462,969
-18% -$385M 5.99% 5
2024
Q4
$1.97B Buy
2,547,982
+292,150
+13% +$242M 5.65% 5
2024
Q3
$2B Sell
2,255,832
-17,858
-0.8% -$16.1M 5.39% 7
2024
Q2
$2.06B Sell
2,273,690
-50,697
-2% -$40.6M 5.58% 5
2024
Q1
$1.81B Buy
2,324,387
+70,395
+3% +$50.1M 4.86% 8
2023
Q4
$1.31B Buy
2,253,992
+255,660
+13% +$149M 3.79% 16
2023
Q3
$1.07B Sell
1,998,332
-66,152
-3% -$34.1M 3.51% 17
2023
Q2
$968M Sell
2,064,484
-56,906
-3% -$23.9M 2.94% 21
2023
Q1
$729M Buy
+2,121,390
New +$715M 2.33% 21
2015
Q1
Sell
-3,000
Closed -$207K 80
2014
Q4
$207K Buy
+3,000
New +$202K ﹤0.01% 74
2014
Q2
Sell
-3,400
Closed -$200K 81
2014
Q1
$200K Buy
+3,400
New +$190K ﹤0.01% 81
2013
Q4
Sell
-4,900
Closed -$247K 87
2013
Q3
$247K Sell
4,900
-100
-2% -$5.24K ﹤0.01% 77
2013
Q2
$246K Buy
+5,000
New +$272K ﹤0.01% 76

Other funds holding LLY

Edgewood Management's LLY Position: Q1 2026 in Review

Edgewood Management reduced its Eli Lilly (LLY) stake by 45% in Q1 2026, selling an estimated $570M and leaving 693,457 shares worth $638M. The position accounts for 4.12% of the portfolio, ranked #12.

Edgewood Management first reported a position in LLY in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.06B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Edgewood Management held 693,457 shares of Eli Lilly worth $638M as of Q1 2026.
  • Edgewood Management sold 562,232 Eli Lilly shares in Q1 2026, an estimated $570M.
  • Eli Lilly made up 4.12% of Edgewood Management's portfolio in Q1 2026, its #12 holding.
  • Edgewood Management first reported a position in Eli Lilly in Q2 2013 and has held it in 17 quarters since.
  • Edgewood Management's Eli Lilly position peaked at $2.06B in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Edgewood Management's 13F filing for Q1 2026, filed 14 May 2026.